Injection site reaction after Fluralaner (Bravecto) in dogs

150 reports to the FDA describe injection site reaction in dogs given Fluralaner. That is 0.2% of all reports for this medicine, compared with 1.0% across reports for all dog medicines, so it is reported less often than average with this medicine.

150Reports
49%Marked serious
16%Recovered
6.0%Died or euthanised
6 daysTypical onset
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

How soon it started

Same day
32 30%
1–2 days
13 12%
3–7 days
20 19%
1–4 weeks
27 25%
Over a month
16 15%

How the animals did

Recovered
24 16%
Still unwell when reported
104 69%
Died
4 2.7%
Euthanised
5 3.3%
Not known
13 8.7%

Problems reported at the same time

Age of the animals

Under 1 year
7
1–3 years
37
4–7 years
56
8–11 years
34
12+ years
8

About this medicine

Fluralaner kills fleas and ticks for up to 12 weeks (chewable or spot-on).

Products with this ingredient include Bravecto. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

In 2018 the FDA alerted owners and vets that isoxazoline products have been associated with neurologic reactions such as muscle tremors, wobbliness (ataxia) and seizures, including in animals with no history of them.

Questions owners ask

Can Fluralaner cause injection site reaction in dogs?
150 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?
In half of the reports with dates, it started within 6 days of the first dose.
What should I do?
Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Injection site reaction with similar medicines

All reported side effects of Fluralaner in dogs · Medicines most reported with injection site reaction